{"id":532926,"date":"2021-03-05T18:30:02","date_gmt":"2021-03-05T18:30:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=532926"},"modified":"2021-03-05T18:30:02","modified_gmt":"2021-03-05T18:30:02","slug":"pharmaceutical-excipients-market-worth-97-billion-by-2025-key-players-are-dupont-de-nemours-inc-us-and-roquette-feres-france","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/pharmaceutical-excipients-market-worth-97-billion-by-2025-key-players-are-dupont-de-nemours-inc-us-and-roquette-feres-france_532926.html","title":{"rendered":"Pharmaceutical Excipients Market Worth $9.7 Billion by 2025 | Key Players are DuPont de Nemours, Inc. (US) and Roquette Feres (France)"},"content":{"rendered":"
\"Pharmaceutical<\/a><\/p>\n
\n
DuPont de Nemours, Inc. (US) and Roquette Feres (France) dominated the global pharmaceutical excipients market in 2018. The prominent players in the global pharmaceutical excipients market are Ashland Global Holdings, Inc. (US), BASF SE (Germany), Evonik Industries AG (Germany), Associated British Foods plc (UK), Archer Daniels Midland Company (US), Lubrizol Corporation(US), and Croda International (UK).<\/div>\n<\/div>\n<\/div>\n
Pharmaceutical Excipients Market Size Estimation and Analysis of Wide Range of Growth Opportunities for Industry Players.<\/div>\n

According to the new market research report “<\/strong>Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohyrates, Petrochemicals) inorganic chemicals), Functionality (Fillers, Diluents, Coatings, Disintegrants), Formulation (Tablet, Capsule, Topical, Parenteral) – Global Forecast to 2025<\/strong>“<\/strong>, published by MarketsandMarkets™, the Pharmaceutical Excipients Market is projected to reach USD 9.7 billion<\/span> by 2025 from USD 6.9 billion<\/span> in 2019, at a CAGR of 5.8%.<\/p>\n

Download PDF Brochure:
<\/strong>https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=956<\/a><\/p>\n

Factors such as the growing pharmaceuticals industry coupled with advancements in functional excipients, rising adoption of orphan drugs, and increasing uptake of biopharmaceuticals, are driving the market for pharmaceutical excipients. The emergence of multifunctional excipients, shifting the focus of pharmaceutical manufacturing to emerging markets, and the growing biosimilars industry also present significant growth opportunities for market players.<\/p>\n

By functionality, the fillers and diluents segment is expected to account for the largest share of the pharmaceutical excipients market in 2019<\/p>\n

<\/strong>The fillers & diluents segment accounted for the largest share of the pharmaceutical excipients market in 2018. This market segment is expected to grow due to the increased use of fillers and diluents in the development and production of solid oral drugs. Oral formulations account for a majority share in the pharmaceutical industry, and as these formulations require fillers and diluents the most, this segment automatically has the majority share of the pharmaceutical excipients market.<\/p>\n

Browse in-depth TOC on<\/em> “<\/strong>Pharmaceutical Excipients Market<\/a><\/strong>“<\/p>\n

<\/strong>220 – Tables
<\/strong>50 – Figures
<\/strong>300 – Pages<\/p>\n

<\/strong>By formulation, the oral formulations segment is estimated to account for the largest share of this market in 2019<\/p>\n

<\/strong>Based on formulation, the pharmaceutical excipients market is segmented into oral, topical, parenteral, and other formulations. In 2018, oral formulations accounted for a major share of the pharmaceutical excipients market, mainly because oral formulations are the most common route of drug delivery. Owing to the shrinking pipeline of new chemical entities (NCEs), companies are increasingly focusing on developing orally disintegrating tablets (ODTs) and other novel methods of oral drug delivery. There is also a growing trend towards sachet formulations.<\/p>\n

The Asia Pacific<\/span> is expected to be the fastest growing the market in 2019<\/p>\n

<\/strong>In 2018, the Asia Pacific<\/span> region was seen as the fastest growing region in the pharmaceutical excipients market. The ease of doing business in the Asia Pacific<\/span> region in terms of reduced regulatory stringency, reduced raw material & labor costs, and a higher target market make this region the fastest growing market in 2019.<\/p>\n

Request Research Sample Pages:
<\/strong>https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=956<\/a><\/p>\n

The key players in the global pharmaceutical excipients market are Ashland<\/span> (US), BASF (Germany<\/span>), DuPont (US), Roquette (France<\/span>), Evonik Industries (Germany<\/span>), Associated British Foods (UK), Archer Daniels Midland Company (US), Lubrizol (US), and Croda International (UK).<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> MarketsandMarkets<\/a>
Contact Person:<\/strong> Mr. Aashish Mehra
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 18886006441
Address:<\/strong>630 Dundee Road Suite 430
City:<\/strong> Northbrook
State:<\/strong> IL 60062
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.marketsandmarkets.com\/Market-Reports\/pharma-excipients-market-956.html<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

DuPont de Nemours, Inc. (US) and Roquette Feres (France) dominated the global pharmaceutical excipients market in 2018. The prominent players in the global pharmaceutical excipients market are Ashland Global Holdings, Inc. (US), BASF SE (Germany), Evonik Industries AG (Germany), Associated … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,406,404],"tags":[],"class_list":["post-532926","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/532926","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=532926"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/532926\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=532926"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=532926"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=532926"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}